Physician profile
Marlon D Gilbert
NPI 1568791457
$1,277.09
in general payments reported to CMS, 2019-2025
16 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $16.97 · 2022: $15.85 · 2023: $630 · 2024: $235 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $225.35 | 2023-2024 | Arexvy, Shingrix |
| Janssen Biotech, INC. | $192.45 | 2023-2025 | Tremfya |
| Genzyme Corporation | $172.23 | 2023-2024 | |
| Pfizer INC. | $158.66 | 2023-2025 | |
| Biotronik INC. | $110.83 | 2019 | |
| Amgen INC. | $93.44 | 2023-2025 | Otezla, Repatha, Evenity |
| Ucb, INC. | $57.85 | 2025 | Bimzelx |
| Alvogen INC | $46.89 | 2024 | Teriparatide |
| Mallinckrodt Hospital Products INC. | $45.53 | 2024 | Acthar |
| Exact Sciences Corporation | $43.51 | 2025 | The Cologuard Plus Collection Kit |
| Radius Health, INC. | $32.71 | 2025 | Tymlos |
| Sanofi Pasteur INC. | $23.40 | 2025 | |
| Abbott Laboratories | $21.49 | 2023 | Proclaim |
| Idorsia Pharmaceuticals US INC | $19.93 | 2023 | Quviviq |
| Allergan, INC. | $16.97 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlon Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.